The Weight Watchers difference: At 6 months, our Med+ members on the GLP-1 Success Program lost 27 lbs, on average.^ ^Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program
Small molecule dipeptidylpeptidase IV inhibitors under investigation for diabetes mellitus therapy
Minimum purity: 98%, supported by batch-specific analytical documentation where applicable
Noom: Behavior meets biology Wraps psychology-based coaching around multiple GLP-1 pathways, including full-dose, microdose, and oral medication options
Which one can I tolerate
Nausea, vomiting, or diarrhea during your first weeks on semaglutide or tirzepatide also increase contraceptive unreliability